$18.27−0.20 (−1.08%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
Artivion (AORT) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~10.2%/yr (FY21→FY25), net margin 2.2%; free cash flow runs at 9% of net income. Check the accrual gap. Worth your attention in FY25: Share count (+21.0%) and Capex step-up ($39.0M). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($K)▲13.6%
441,330.0
FY21→FY25CAGR +10.2%/yr
Net income ($K)—
9,768.0
one-off year: see footnoteCAGR —
Free cash flow ($K)▼92.4%
839.0
capex stepped upCAGR —
Diluted EPS—
0.21
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+21.0%
39.0mn → 47.2mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Capex step-up
$39.0M
▲249% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
2¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 66.1% → 64.4%. Net margin 2.2% is below the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 481,876.0 | 441,330.0 | 388,537.0 | 354,004.0 | 313,789.0 | 298,836.0 | ▲13.6% | +10.2% |
Cost of revenue | 176,791.0 | 157,103.0 | 139,756.0 | 124,828.0 | 111,266.0 | 101,322.0 | ▲12.4% | +11.6% |
Gross profit | 305,085.0 | 284,227.0 | 248,781.0 | 229,176.0 | 202,523.0 | 197,514.0 | ▲14.2% | +9.5% |
Research & development | 36,826.0 | 30,991.0 | 28,452.0 | 28,707.0 | 38,879.0 | 35,546.0 | ▲8.9% | −3.4% |
Selling, general & admin | 260,709.0 | 226,491.0 | 181,455.0 | 208,977.0 | 157,443.0 | 169,774.0 | ▲24.8% | +7.5% |
Total operating expenses | 294,035.0 | 250,482.0 | 209,907.0 | 223,434.0 | 196,322.0 | 189,397.0 | ▲19.3% | +7.2% |
Operating incomefeeds ROC rank | 11,050.0 | 33,745.0 | 38,874.0 | 5,742.0 | 6,201.0 | 8,117.0 | ▼13.2% | +42.8% |
Other income, net | −21,793.0 | −18,965.0 | −46,388.0 | −27,328.0 | −21,185.0 | −22,944.0 | — | — |
Pretax income | −10,743.0 | 14,780.0 | −7,514.0 | −21,586.0 | −14,984.0 | −14,827.0 | — | — |
Income tax | 6,850.0 | 5,012.0 | 5,845.0 | 9,104.0 | 4,208.0 | 7.0 | ▼14.3% | +417.3% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | −17,593.0 | 9,768.0 | −13,359.0 | −30,690.0 | −19,192.0 | −14,834.0 | — | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −0.35 | 0.21 | −0.32 | −0.75 | −0.48 | −0.38 | — | — |
Diluted shares (mn) | 48.72 | 47.16 | 41.68 | 40.74 | 40.03 | 38.98 | ▲13.2% | +4.9% |
| Margins | ||||||||
Gross margin45th pct in Healthcare | 63.3% | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% | ▲0.4pp | −1.7pp |
Operating margin | 2.3% | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% | ▼2.4pp | +4.9pp |
Net margin33rd pct in Healthcare | −3.7% | 2.2% | −3.4% | −8.7% | −6.1% | −5.0% | ▲5.7pp | +7.2pp |
† TTM = trailing four quarters through 2026-09-30.FY21 effective tax rate was −0% vs a −28% norm for this window, likely a one-time item; see the filing.FY23 effective tax rate was −42% vs a −28% norm for this window, likely a one-time item; see the filing.
5 more years of statements and CSV export are on Premium, and 12 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-18 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Artivion's revenue last fiscal year?
Artivion reported revenue of $441,330.0K in fiscal 2025, up 13.6% from fiscal 2024.
What was Artivion's net income?
Artivion reported net income of $9,768.0K in fiscal 2025, a net margin of 2.2%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

